Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  CJEM

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S1481803500007508PMID 17608990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for the Medical Management of Osteoarthrits of the Hip and Knee

  2002cited by this paper
• Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

  2002cited by this paper
• The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties.

  2001cited by this paper
• Acute renal failure related to high-dose celecoxib.

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.

  2001cited by this paper
• Cyclooxygenase-2 Inhibition and Renal Function

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure.

  2001cited by this paper
• Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

  2001cited by this paper
• Selective reporting of pharmaceutical data leads major medical journals to change editorial policy.

  2001cited by this paper
• Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.

  2001cited by this paper
• Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.

  2001cited by this paper
• Possible Celecoxib-Induced Gastroduodenal Ulceration

  2001cited by this paper
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• Cyclooxygenase-2 Inhibition and Renal Function

  2001cited by this paper
• Guidelines for diagnosis and treatment of high cholesterol.

  2001cited by this paper
• Cyclooxygenase-2–Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

  2001cited by this paper
• Rofecoxib safe in NSAID hypersensitivity

  2001cited by this paper
• Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.

  2001cited by this paper
• Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: a prospective, randomized, double-blinded, placebo-controlled trial.

  2001cited by this paper
• Risk of cardiovascular events associated with selective COX-2 inhibitors.

  2001influential reference
• Rofecoxib as an alternative in aspirin hypersensitivity

  2001cited by this paper
• Upper Gastroduodenal Ulceration in Arthritis Patients Treated with Celecoxib

  2001cited by this paper
• Journal supplements and evidence-based medicine.

  2001cited by this paper
• Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis

  2001cited by this paper
• Inhibition of COX-2 counteracts the effects of diuretics in rats.

  2001cited by this paper
• Cardiovascular events and COX-2 inhibitors.

  2001cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

  2000cited by this paper
• Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

  2000cited by this paper
• Effects of celecoxib and naproxen on renal function in the elderly.

  2000cited by this paper
• An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference.

  2000influential reference
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial

  2000cited by this paper
• Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000influential reference
• COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs

  2000cited by this paper
• Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers

  2000cited by this paper
• Correction: Catheter-Related Bloodstream Infections

  2000cited by this paper
• Magda Segal: Picturing women's health

  2000cited by this paper
• Are selective COX-2 inhibitors nephrotoxic?

  2000cited by this paper
• 28 Days

  2000cited by this paper
• The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials.

  2000cited by this paper
• Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.

  2000cited by this paper
• Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet

  2000cited by this paper
• Celecoxib (Celebrex): 1 year later.

  2000cited by this paper
• A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group.

  1999cited by this paper
• Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a canadian community hospital

  1999cited by this paper
• Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects

  1999cited by this paper
• Cyclooxygenase‐2 inhibition by rofecoxib reverses naturally occurring fever in humans

  1999cited by this paper
• Immunologic tolerability profile of celecoxib.

  1999cited by this paper
• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats

  1998cited by this paper
• Relative safety of meloxicam in NSAID‐intolerant patients

  1998cited by this paper
• Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.

  1998cited by this paper
• Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

  1997cited by this paper
• Colorectal cancer and nonsteroidal anti-inflammatory drugs.

  1997cited by this paper
• Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.

  1997cited by this paper
• Bleeding peptic ulcer.

  1994cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• Bleeding peptic ulcer.

  1952cited by this paper

• Efficacy of Cyclooxygenase-2 Inhibitors for Headache in Acute Brain Injury: A Systematic Review

  2024cites this paper
• Cyclooxygenase 2 Inhibitors for Headache After Elective Cranial Neurosurgery: Results from a Systematic Review of Efficacy of Cyclooxygenase 2 Inhibitors for Headache After Acute Brain Injury

  2024cites this paper
• Toward a broader view of mechanisms of drug cardiotoxicity

  2021cites this paper
• Celecoxib for the treatment of musculoskeletal arthritis

  2019cites this paper
• Dosierung und Toxizität von Antirheumatika bei Niereninsuffizienz

  2015cites this paper
• TheF utureo fO steoarthritisT herapeutics:T argeted Pharmacological Therapy

  2013cites this paper
• Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models

  2013cites this paper
• Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

  2013cites this paper
• The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy

  2013cites this paper
• Das Analgetika-Asthma-Syndrom

  2013cites this paper
• In vivo and in vitro anti-inflammatory activity of Lentinus polychrous extract.

  2013cites this paper
• LINSEED AND LINSEED OIL : HEALTH BENEFITS-A REVIEW

  2013cites this paper
• Intra-articular drug delivery: the challenge to extend drug residence time within the joint.

  2011cites this paper
• Anti-inflammatory and ethopharmacological effects of an ethanolic leaf extract of Palisota Hirsuta K. Schum. (Commelinaceae)

  2009cites this paper
• The science behind dietary omega-3 fatty acids

  2008cites this paper
• Emergency Sedation and Pain Management: Plate section

  2008cites this paper
• Effects of short- and long-term celecoxib on orthodontic tooth movement.

  2008cites this paper
• Basic pharmacology and advances in emergency medicine.

  2005influential citation
• Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects

  2003cites this paper